Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
暂无分享,去创建一个
J. Hiatt | A. Zarrinpar | D. Markovic | R. Busuttil | V. Agopian | J. McWilliams | F. Kaldas | Michael P. Harlander‐Locke | D. Farmer | M. Morshedi | H. Yersiz
[1] A. Israni,et al. Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States , 2015, Hepatology.
[2] Ali Zarrinpar,et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. , 2015, Journal of the American College of Surgeons.
[3] W. Kim,et al. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] J. Emond,et al. Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment , 2014, Hepatology.
[5] J. Roberts,et al. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] R. Hirose,et al. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] M. Pompili,et al. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. , 2013, World journal of gastroenterology.
[8] Massimo Rossi,et al. Alpha‐fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] Johnny C. Hong,et al. The Evolution of Liver Transplantation During 3 Decades: Analysis of 5347 Consecutive Liver Transplants at a Single Center , 2013, Annals of surgery.
[10] A. Burroughs,et al. Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[11] E. Vittinghoff,et al. Offer patterns of nationally placed livers by donation service area , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] R. Wiesner,et al. Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease , 2013, Transplantation.
[13] Peter G. Stock,et al. OPTN/SRTR 2011 Annual Data Report: Liver , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] M. Reiser,et al. Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation , 2012, Digestion.
[15] S. Kwan,et al. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological‐pathological correlation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[16] F. Piscaglia,et al. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] B. Caffo,et al. MELD Exceptions and Rates of Waiting List Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] P. Majno,et al. Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] P. Morel,et al. The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. , 2011, Journal of hepatology.
[20] A. Cucchetti,et al. Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation? , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] M. Carpenzano,et al. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas , 2011, Hepatology.
[22] A. Venook,et al. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[23] R. Freeman,et al. Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] A. Frigo,et al. Response to Therapy as a Criterion for Awarding Priority to Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation , 2010, Annals of Surgical Oncology.
[25] Riccardo Lencioni,et al. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.
[26] W. Chapman,et al. Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation , 2008, Annals of surgery.
[27] Ryutaro Hirose,et al. Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis , 2008, Hepatology.
[28] G. Ioannou,et al. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. , 2008, Gastroenterology.
[29] T. Serrano,et al. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. , 2008, AJR. American journal of roentgenology.
[30] R. Merion,et al. Liver and Intestine Transplantation in the United States, 1997–2006 , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[31] W. Jaschke,et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[32] T. Pfammatter,et al. Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence‐Based Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] G. Otto,et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[34] M. Pompili,et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[35] Sammy Saab,et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation , 2005, Hepatology.
[36] L. Mariani,et al. Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study , 2004, Annals of surgery.
[37] G. Klintmalm,et al. Liver and intestine transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] R. Wiesner,et al. Liver and intestine transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] A. Venook,et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.
[40] H. Bismuth,et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. , 1997, Annals of surgery.
[41] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[42] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[43] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.